EEF2K and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Additionally, we show that pharmacological inhibition of eEF2K ameliorated the altered EEG phenotype, demonstrating that treatments aimed to decrease eEF2K activity might represent a new approach for treating patients that are affected by Dravet syndrome.